We are live on ! Find out more
NVNO

enVVeno Medical
NVNO

17 hedge funds and large institutions have $1.02M invested in enVVeno Medical in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

14.41% more ownership

Funds ownership: 0.93% → 15.33% (+14%)

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

52% less capital invested

Capital invested by funds: $2.1M → $1.02M (-$1.08M)

53% less funds holding

Funds holding: 36 → 17 (-19)

74% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 23

Holders
17
Holders Change
-19
Holders Change %
-52.78%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
5
Closed
23
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$51.5K
2
TRCT
Tower Research Capital (TRC)
New York
+$5.93K
3
BlackRock
BlackRock
New York
+$1.23K
4
Wells Fargo
Wells Fargo
California
+$624
5
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$22

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$564K
2
GCP
GSA Capital Partners
United Kingdom
-$64K
3
Jane Street
Jane Street
New York
-$57.4K
4
Two Sigma Investments
Two Sigma Investments
New York
-$51.2K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$42.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
XT
26
XTX Topco
Cayman Islands
– -$21.6K -1,920 Closed
TSS
27
Two Sigma Securities
New York
– -$20.1K -1,788 Closed
Renaissance Technologies
28
Renaissance Technologies
New York
– -$16.5K -1,466 Closed
HF
29
HRT Financial
New York
– -$15K -1,407 Closed
Citadel Advisors
30
Citadel Advisors
Florida
– -$13.7K -1,221 Closed
State Street
31
State Street
Massachusetts
– -$13.1K -1,166 Closed
Northern Trust
32
Northern Trust
Illinois
– -$12.2K -1,088 Closed
FA
33
Fermata Advisors
California
– -$10.5K -935 Closed
AQR Capital Management
34
AQR Capital Management
Connecticut
– -$6.71K -597 Closed
Creative Planning
35
Creative Planning
Kansas
– -$6.71K -597 Closed
Two Sigma Advisers
36
Two Sigma Advisers
New York
– -$4.49K -400 Closed
Cambridge Investment Research Advisors
37
Cambridge Investment Research Advisors
Iowa
– -$3K -286 Closed
Bank of America
38
Bank of America
North Carolina
– -$648 -58 Closed
WAM
39
Wolverine Asset Management
Illinois
– -$567 -51 Closed
Jones Financial Companies
40
Jones Financial Companies
Missouri
– -$6 -1 Closed
1
2

NVNO Hedge Fund Activity: Q1 2026 in Review

17 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q1 2026, worth a combined $1.02M — down 52% from $2.1M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of NVNO and 6 opened new positions — a net loss of 17 holders — while 5 trimmed existing stakes and 3 added.

The largest buyer was Geode Capital Management, adding an estimated $51.5K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $564K sold.

  • 17 institutional investors held enVVeno Medical (NVNO) as of Q1 2026, down from 36 in Q4 2025.
  • Funds reported $1.02M of enVVeno Medical stock for Q1 2026, down 52% quarter-over-quarter.
  • 6 funds opened new enVVeno Medical positions in Q1 2026 and 23 closed out, a net change of -17 holders.
  • The largest enVVeno Medical buyer in Q1 2026 was Geode Capital Management, an estimated $51.5K added.
  • The largest enVVeno Medical seller in Q1 2026 was Perceptive Advisors, an estimated $564K sold.

Based on aggregated 13F filings for Q1 2026.